Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

As pesticides and wildfires rise, kids with cancer need resources

2.

Taking vitamin D daily decreased cancer mortality, according to a study.

3.

Recurrent UTIs impact eGFR in children with vesicoureteral reflux

4.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

5.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot